• |
NEW PROJECTS
Investigation on Paromomycin resistance in Leishmania donovani using molecular and biochemical tools.
Dr. Poonam Salotra and Dr. Ruchi Singh, ICMR, 2015-2018. |
• |
Identification and characterization of artemisinin resistance associated genes in Leishmania.
Dr. Ruchi Singh and Dr.Poonam Salotra, ICMR, 2015- 2018. |
• |
Virtual Centre of Excellence on multidisciplinary approaches aimed at interventions against Mycobacterium tuberculosis (Phase I1).
Dr. Nasreen Ehtesham, DBT, 2015-2019. |
• |
Role of Long Non-coding RNA MEG3 in Breast Carcinogeneis
Dr. S.A. Raju Bagadi, DST, 2016-19. |
• |
Study of HLA-DR3 and/ or DQ2 restricted CD4+T cells in Type 1 diabetes in North India (Approved by SERB, Jan 2016).
Dr. Neeraj Kumar, DST-SERB, 2016-2019. |
• |
Autoantibody response and identification of tumor-associated antigens in gall bladder carcinoma-immunoproteomics approach.
Dr. Poonam Gautam, DST-SERB, 2015-17.
|
• |
ONGOING PROJECTS
Study on micro RNA signature associated with Breast cancer stem cells (CSCs) and their role in drug response.
Dr. Sunita Saxena, Dr. SA Raju, ICMR (2012-2016) |
• |
Targetted sequencing of breast cancer specific genes in early-onset breast carcinoma.
Dr. Sunita Saxena, Dr. SA Raju ICMR, (2013-2016). |
• |
Understanding the role of micronutrients in Mycobacterium tuberculosis infection using guinea pig as a model.
Dr. Nasreen Ehtessham, ICMR (2013-2017). |
• |
Differential protein profile for identification of markers in recurrent urothelial cancer.
Dr. Usha Agrawal ICMR-SRF (2014-2016) |
• |
Genome wide analysis of genetic alterations and gene expression profile in hormone sensitive and hormone refractory prostate cancer.
Dr. Anju Bansal, ICMR (2014-2017).
|
• |
COMPLETED PROJECTS
Understanding the role of androgen receptor signaling in breast cancer.
Dr. Sunita Saxena ICMR (2013-2015) |
• |
Study of characterization of TMPRESS2: ERG and PCA3 as prostate cancer biomarkers in Indian Patients.
Dr. Sunita Saxena, Dr. Anju Bansal ICMR (2013-2015). |
• |
Development of new live-attenuated vaccines candidates for kala-azar.
Dr. Poonam Salotra DBT, (2011-2015) |
• |
Virtual Centre of Excellence on multidisciplinary approaches aimed at interventions against Mycobacterium tuberculosis (Phase 1).
Dr. Nasreen Ehtesham DBT, |
• |
Immunopathogenesis of Reactive Arthritis induced by Chlamydia trachomatis.
Dr. Sangita Rastogi, ICMR-SRF, (2010-2015) |
• |
Understanding the role of chemokines and their receptors in growth and development of glioblastoma.
Dr. Avninder P Singh ICMR, (2014-2016) |
• |
Development of new live-attenuated vaccines candidates for kala-azar.
Dr. Poonam Salotra DBT, (2011-2015) |
